rs2075789
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_172166.4(MSH5):c.85C>T(p.Pro29Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0982 in 1,526,338 control chromosomes in the GnomAD database, including 8,609 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_172166.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSH5 | NM_172166.4 | c.85C>T | p.Pro29Ser | missense_variant | 2/25 | ENST00000375750.9 | NP_751898.1 | |
MSH5-SAPCD1 | NR_037846.1 | n.213C>T | non_coding_transcript_exon_variant | 2/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSH5 | ENST00000375750.9 | c.85C>T | p.Pro29Ser | missense_variant | 2/25 | 1 | NM_172166.4 | ENSP00000364903 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0930 AC: 14131AN: 152010Hom.: 830 Cov.: 31
GnomAD3 exomes AF: 0.126 AC: 15944AN: 126162Hom.: 1217 AF XY: 0.123 AC XY: 8464AN XY: 68762
GnomAD4 exome AF: 0.0988 AC: 135706AN: 1374210Hom.: 7777 Cov.: 31 AF XY: 0.0991 AC XY: 67201AN XY: 678122
GnomAD4 genome AF: 0.0930 AC: 14142AN: 152128Hom.: 832 Cov.: 31 AF XY: 0.0996 AC XY: 7406AN XY: 74376
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
MSH5-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 24, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at